NEWS
SUBSCRIBER SEARCH (Requires Login)
  NEW DRUGS
  MARKETED DRUGS
  COMPANY
  TARGETS IN ONCOLOGY
  NEWS SUMMARIES
  COMBINATION TRIALS

Latest Updates

November 2009 Marketed Drug Updates and Additions

Brand Name

Generic Name

Other Designation

Folotyn

Pralatrexate

PDX

Oncophage

Vitespen

HSPPC-96

Eloxatin, Eloxatine, Elplat (Japan)

Oxaliplatin (L-OHP)

1670RB, RP 54780

Arzerra

Ofatumumab

HuMax-CD20, GSK1841157

Votrient (formerly Armala)

Pazopanib HCl

GW786034, 786034

Istodax

Romidepsin

FR901228, FK228, NSC630176

 

Oxaliplatin

 

Polyphenon E Ointment, Veregen

 

 

Megace oral solution and Megace ES

Megestrol acetate

 

Taxotere

Docetaxel

RP 56976, NSC 628503

Zadaxin

Thymalfasin

 

 

Oxaliplatin

 

 

Oxaliplatin

 

  

Home   |    Freelance Opportunities   |   New Medicine   |   Site Map   |  Order/Inquiry   
SUBSCRIBER SEARCH:   NEW DRUG   |   MARKETED DRUG   |   COMPANY   |   TARGETS IN ONCOLOGY  

NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE:  1-949-830-0448     FAX:  1-949-830-0887
INFO@NEWMEDINC.COM